Looking ahead, efforts may focus on identifying reliable biomarkers of response to ICIs and targeted agents in BTC, clarifying the role of PD‐L1 expression, microsatellite instability, mismatch repair, tumor mutational burden, DNA damage repair alterations, and other emerging predictors.7, 12. Here, CD274 is linked to neoplasm.